Erratum: Clarifying intact 3D tissues on a microfluidic chip for high-throughput structural analysis (Proceedings of the National Academy of Sciences of the United States of America (2016) 113 (14915-14920) DOI: 10.1073/pnas.1609569114);Clarifying intact 3D tissues on a microfluidic chip for high-throughput structural analysis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 52, 2016, Pages 14915-14920

  Chen, Yih Yang ^a   Silva, Pamuditha N ^a   Syed, Abdullah Muhammed ^a   Sindhwani, Shrey ^a   Rocheleau, Jonathan V ^a,b,c   Chan, Warren C W ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

3D imaging; CLARITY; Computational analysis; Fluorescence imaging; Microfluidic

Indexed keywords

ACRYLAMIDE; DOXORUBICIN; IMATINIB; MONOMER; SUNITINIB; TRANSFERRIN RECEPTOR;

ADVECTION; ALGORITHM; ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL DEATH; CELL TRANSPLANTATION; CENTRIFUGATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS LINKING; DIFFUSION COEFFICIENT; FLOW RATE; FLUORESCENCE; FLUORESCENCE IMAGING; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HYDROGEL; IMAGE ANALYSIS; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL FLUID; MEMBRANE DAMAGE; MICROFLUIDICS; MOUSE; NONHUMAN; PANCREAS ISLET; POLYMERIZATION; PRIORITY JOURNAL; SHEAR STRESS; STAINING; STRUCTURE ANALYSIS; SURFACE AREA; SURFACE TENSION; TISSUE PRESERVATION; TISSUE STRUCTURE; TUMOR SPHEROID; VASCULARIZATION; VELOCITY;

EID: 85007422312     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1700238114     Document Type: Erratum

References (33)

1. Mordwinkin NM, Burridge PW, Wu JC (2013) A review of human pluripotent stem cellderived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards. J Cardiovasc Transl Res 6(1):22-30.
2. Held MA, et al. (2013) Genotype-selective combination therapies for melanoma identified by high-throughput drug screening. Cancer Discov 3(1):52-67.
3. Astashkina A, Mann B, Grainger DW (2012) A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacol Ther 134(1):82-106.
4. Hirschhaeuser F, et al. (2010) Multicellular tumor spheroids: An underestimated tool is catching up again. J Biotechnol 148(1):3-15.
5. Goodman TT, Ng CP, Pun SH (2008) 3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers. Bioconjug Chem 19(10):1951-1959.
6. Wu LY, Di Carlo D, Lee LP (2008) Microfluidic self-assembly of tumor spheroids for anticancer drug discovery. Biomed Microdevices 10(2):197-202.
7. Hsiao AY, et al. (2009) Microfluidic system for formation of PC-3 prostate cancer coculture spheroids. Biomaterials 30(16):3020-3027.
8. Wlodkowic D, Cooper JM (2010) Tumors on chips: Oncology meets microfluidics. Curr Opin Chem Biol 14(5):556-567.
9. Albanese A, Lam AK, Sykes EA, Rocheleau JV, Chan WC (2013) Tumour-on-A-chip provides an optical window into nanoparticle tissue transport. Nat Commun 4:2718.
10. Pampaloni F, Ansari N, Stelzer EHK (2013) High-resolution deep imaging of live cellular spheroids with light-sheet-based fluorescence microscopy. Cell Tissue Res 352(1):161-177.
11. Bersini S, et al. (2014) A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone. Biomaterials 35(8):2454-2461.
12. Rajadhyaksha M, Grossman M, Esterowitz D, Webb RH, Anderson RR (1995) In vivo confocal scanning laser microscopy of human skin: Melanin provides strong contrast. J Invest Dermatol 104(6):946-952.
13. Shotton DM (1989) Confocal scanning optical microscopy and its applications for biological specimens. J Cell Sci 94(2):175-206.
14. Cavanagh HD, et al. (1993) Clinical and diagnostic use of in vivo confocal microscopy in patients with corneal disease. Ophthalmology 100(10):1444-1454.
15. Hell S, Reiner G, Cremer C, Stelzer EHK (1993) Aberrations in confocal fluorescence microscopy induced by mismatches in refractive index. J Microsc 169(3):391-405.
16. Chung K, Deisseroth K (2013) CLARITY for mapping the nervous system. Nat Methods 10(6):508-513.
17. Tomer R, Ye L, Hsueh B, Deisseroth K (2014) Advanced CLARITY for rapid and highresolution imaging of intact tissues. Nat Protoc 9(7):1682-1697.
18. Chung K, et al. (2013) Structural and molecular interrogation of intact biological systems. Nature 497(7449):332-337.
19. Yang B, et al. (2014) Single-cell phenotyping within transparent intact tissue through whole-body clearing. Cell 158(4):945-958.
20. Sindhwani S, et al. (2016) Three-dimensional optical mapping of nanoparticle distribution in intact tissues. ACS Nano 10(5):5468-5478.
21. Kim S-Y, et al. (2015) Stochastic electrotransport selectively enhances the transport of highly electromobile molecules. Proc Natl Acad Sci USA 112(46):E6274-E6283.
22. Epp JR, et al. (2015) Optimization of CLARITY for clearing whole-brain and other intact organs. eNeuro 2(3):ENEURO.0022-15.2015.
23. Ivascu A, Kubbies M (2007) Diversity of cell-mediated adhesions in breast cancer spheroids. Int J Oncol 31(6):1403-1413.
24. Silva PN, et al. (2016) Highly efficient adenoviral transduction of pancreatic islets using a microfluidic device. Lab Chip 16(15):2921-2934.
25. El-Gohary Y, et al. (2012) Three-dimensional analysis of the islet vasculature. Anat Rec (Hoboken) 295(9):1473-1481.
26. Choi NW, et al. (2007) Microfluidic scaffolds for tissue engineering. Nat Mater 6(11): 908-915.
27. Hsu Y-H, et al. (2013) Full range physiological mass transport control in 3D tissue cultures. Lab Chip 13(1):81-89.
28. Foty RA, Steinberg MS (2005) The differential adhesion hypothesis: A direct evaluation. Dev Biol 278(1):255-263.
29. Brissova M, Powers AC (2008) Revascularization of transplanted islets: Can it be improved? Diabetes 57(9):2269-2271.
30. Phelps EA, Headen DM, Taylor WR, Thulé PM, García AJ (2013) Vasculogenic biosynthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes. Biomaterials 34(19):4602-4611.
31. Bruni A, Gala-Lopez B, Pepper AR, Abualhassan NS, Shapiro AJ (2014) Islet cell transplantation for the treatment of type 1 diabetes: Recent advances and future challenges. Diabetes Metab Syndr Obes 7:211-223.
32. Shapiro AMJ (2012) Islet transplantation in type 1 diabetes: Ongoing challenges, refined procedures, and long-term outcome. Rev Diabet Stud 9(4):385-406.
33. Nyqvist D, Köhler M, Wahlstedt H, Berggren PO (2005) Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts. Diabetes 54(8):2287-2293.